Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000402201 | SCV000343410 | uncertain significance | not provided | 2016-07-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001062654 | SCV001227469 | uncertain significance | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2021-08-26 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with tryptophan at codon 8470 of the SYNE1 protein (p.Arg8470Trp). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs375616724, ExAC 0.001%). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 289116). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000402201 | SCV003825318 | uncertain significance | not provided | 2019-09-06 | criteria provided, single submitter | clinical testing |